ANGEL PEÑA
Updated Thursday, December 5, 2019 - 10:50 pm
- Share on Facebook
- Share on Twitter
- Send by email
Something fat had been cooking at Grifols for some time. This Friday, its scientific chefs are scheduled to be crowned in California, the innovation mecca. The Catalan pharmaceutical company, which started with a small laboratory in 1909 and has become a multinational with all the letters, presents this Friday at the International Conference of Clinical Trials on Alzheimer's Disease in San Diego the latest update of its Ambar study, Acronym for Alzheimer Management by Albumin Rep
To continue reading, become Premium
Are you already Premium? Log in
Monthly
Launching offer
€ 1
first month
after € 7.99
I want itDiscover what is Premium
Cancel whenever you want
Check the terms and conditions of the service
According to the criteria of The Trust Project
Know more